Report Highlights
The U.S. market for kidney failure treatment will grow from $39.4 billion in 2016 to nearly $45.6 billion by 2021, with a compound annual growth rate (CAGR) of 3.0% for the period of 2016-2021.
Report Includes
- An in-depth analysis of the market for kidney failure treatment products and services, forecasting growth and trends in various sectors.
- Analyses of market trends, with data from 2015, 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Detailed coverage of products and services including those for treating acute renal failure, chronic renal failure, and end-stage renal disease, the final phase of chronic kidney failure.
- Specfic segmentation of the market into pharmaceuticals used to address the conditions associated with kidney failure (i.e., hypertension, diabetes, and anemia); hemodialysis and peritoneal dialysis products and services; and surgical procedures used to keep the end-stage kidney patient alive (i.e., surgeries to create vascular access sites for dialysis, and kidney transplantation).
- Evaluation of the industry structure and dynamics, as well as technological developments.
- Profiles of major players in the industry.
SCOPE OF REPORT
Five-year projections for market activity and value are provided. Treatment types and trends for acute and chronic kidney failure, pricing considerations for medications, dialysis products (dialysis machines, dialysates and dialyzers) and therapies, and surgical procedures, companies, industry structure, and participating companies are included in the study.
Breakdowns:
- Therapeutic products.
- Anemia.
- Diabetic nephropathy.
- Hyperkalemia.
- Hypertension.
- Renal replacement therapy.
- Hemodialysis.
- Intermittent hemodialysis.
- Continuous renal replacement therapy (CRRT).
- Peritoneal.
- Continuous ambulatory peritoneal dialysis (CAPD).
- Continuous cycling peritoneal dialysis (CCPD).
- Renal transplantation.
Other related topics discussed include the diagnosis criteria, leading pharmaceutical companies and the competitive landscape. The market analysis is based on the regional, demographic and treatment options.
The report includes analysis of leading and emerging competitors in the current worldwide diagnostic market for kidney diseases. Profiles of manufacturers of leading products as well as biotechnology companies with products in development are discussed, along with their specific product strategies. Detailed profiles of current market leaders are included, as well as profiles of companies with innovative products poised to advance within the forecast period. Market figures are based on revenues at the manufacturers’ level and are projected at 2016-dollar value. Inflation is not computed into projection figures. Trends are assessed based on projected sales for existing products, new product introductions, expanded indications for existing products and projected changes in the prevalence of diagnosis for respective diseases. In addition, the report includes forecasts by product, product category and company from 2014 through 2021. The study is arranged to offer an overview of the diagnostic market accompanied by product, company and region.
Excluded from this report are treatments for the less-common kidney diseases, including polycystic kidney disease, Immunogloblin A (IgA) nephropathy, nephrotic syndrome and minimal change disease.. Sales figures are reported in U.S. dollars and in each case reflect currency fluctuations within the performance of sales change. Sales figures do not account for variation in local currencies. All market share data presented are on a global basis unless specifically noted.
ANALYST'S CREDENTIALS
Cheng-Yuk Lee is a life sciences researcher and engineer. He has experience in preclinical and translational medicine research in a pharmaceutical company and led several in vitro diagnostic assay developments as a senior scientist in multiple diagnostic companies. He received a dual bachelor of science degree in chemical engineering and biochemistry and subsequently completed his Ph.D. in chemical engineering and postdoctoral training. Prior to his professional career, he provided marketing research and strategic business planning for the Office of Corporate Relations at a public research university.
Related Reports
Biosimilars: Global Markets
The global biosimilars market was valued at $23.8 billion in 2023. The market is expected to grow from $28.5 billion in 2024 to $69.2 billion by 2029, at a compound annual growth rate (CAGR) of 19.4% from 2024 through 2029.
Global Markets for Diabetes Therapeutics and Diagnostics
The global market for diabetes therapeutics and diagnostics is estimated to increase from $102.2 billion in 2023 to reach $132.0 billion by 2028, at a compound annual growth rate (CAGR) of 5.2% from 2023 through 2028.
Renal Dialysis Equipment: Technologies and Global Markets
The global market for renal dialysis equipment is estimated to increase from $17.8 billion in 2022 to reach $23.6 billion by 2027, at a compound annual growth rate (CAGR) of 5.8% from 2022 through 2027.
Renal Biomarkers: Technologies and Global Markets
The global market for renal biomarkers is estimated to increase from $1.2 billion in 2022 to reach $1.7 billion by 2027, at a compound annual growth rate (CAGR) of 7.6% from 2022 through 2027.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Patient Monitoring Devices: Global Markets
The global market for patient monitoring devices is expected to grow from $36.7 billion in 2025 and is projected to reach $55.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.7% during the forecast period of 2025 to 2030.
Biological and Medical Imaging Reagents: Global Markets
The global market for biological and medical imaging reagents is estimated to grow from $26.6 billion in 2025 and forecast to reach $40.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2030.
Anesthesia and Respiratory Devices: Global Markets
The global market for anesthesia and respiratory devices is expected to grow from $51.9 billion in 2025 and is projected to reach $74.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2025 to 2030.
Tissue Engineering and Regeneration: Technologies and Global Markets
The global market for tissue engineering and regeneration was valued at $4.8 billion in 2024 and is estimated to increase from $5.4 billion in 2025 to reach $9.8 billion by 2030, at a compound annual growth rate (CAGR) of 12.8% from 2025 through 2030.
6G in Healthcare: Global Market
This report provides an analysis of the global market trends for 6G in healthcare. It focuses on the significant driving trends and challenges that affect the global market. The report concludes with an analysis of the competitive landscape, which provides the ranking/share of key companies in the global market for 6G in healthcare.
Report Highlights
- Overall sales in the global market for renal failure treatmentwere worth nearly $28 billion in 2009, it is estimated to increase to $33.5 billion at a 5 year compound annual growth rate (CAGR) of 3.7%.
- The largest segment CKD treatment products and therapies (including dialysis consumables) market was nearly $26.5 billion in 2009. This is expected to rise to $31.7 billion in 2014, at a CAGR of 3.6%.
- ARF treatment products and therapies (including dialysis consumables) market reached $955 million in 2009 and is projected to reach $1.4 billion in 2014, at a CAGR of 8.7%.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More